What is Anakinra?

Category: Prescription Drugs

Most popular types: Kineret

false

Anakinra is a disease modifying antirheumatic, interleukin-1 receptor antagonist. It is used in the treatment of moderately- to severely-active rheumatoid arthritis in adult patients who have failed one or more disease-modifying antirheumatic drugs (DMARDs).

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Adult Still's disease 5 2
Fever 2 0
Rheumatoid arthritis 2 0
Doctor recommendation 1 0
Rash on torso 1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
2
None
0

Commonly reported side effects and conditions associated with Anakinra

Side effect Patients
Allergies 1
Injection site reaction 1
Rashes (redness, swelling) 1

Dosages

Based on patients currently taking Anakinra

Dosage Patients
100 mg m,w,f 1
100 mg/0.67 mL daily 1
100 mg daily 1

Why patients stopped taking Anakinra

Multiple reasons could be selected

Reason Patients
Did not seem to work 4
Doctor's advice 3
Other 1
See all 5 patients who've stopped taking Anakinra

Duration

Currently taking Anakinra

Duration Patients
6 months - 1 year 1
2 - 5 years 1
5 - 10 years 1

Stopped taking Anakinra

Duration Patients
1 - 6 months 1
6 months - 1 year 2
1 - 2 years 1
2 - 5 years 1
Adherence
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 1
$25-49 0
< $25 0
Not specified 1

What people switch to and from

Patients started taking Anakinra after stopping:

Treatment Patients
Prednisone (Deltasone) 2
Cyclosporine (Neoral) 1
Etanercept (Enbrel SureClick) 1
Infliximab (Remicade) 1
Tocilizumab (Actemra) 1

Patients stopped taking Anakinra and switched to:

Treatment Patients
Adalimumab (Humira) 1
Golimumab (Simponi SmartJect) 1
Last updated:
There are no evaluations for Anakinra.